Health
Three lessons from Covid-19 on accelerating biopharma innovation – STAT
Innovation in biopharma research and development being wrought by Covid-19 will improve R&D in cancer and other fields.
The health care research ecosystem has shifted into overdrive in response to Covid-19, sparking unprecedented speed and agility. The economic and public health burdens it has generated demand that we rethink our approach to developing new vaccines and therapies. Researchers are now examining what we can learn from these experiences and more broadly apply this innovation to research and development in the future.
As we look back at the past few months, I see three lessons that health care resear…
-
Noosa News24 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal